Our goal is a world where prevention comes first, disease is caught earlier, and ultimately, we are better able to predict who will get sick and proactively treat patients before disease takes hold. Providence believes that genomic testing and research are the keys to unlocking this predictive future. Together, we open the door to precision medicine, enabling us to offer personalized care that is participatory and preventative.
Human genetics are changing the way physicians and researchers approach diagnosis, treatment, and care. It is natural to have questions as you seek to learn more about which genomic research and tests may be relevant to your patients.
We invite you to visit the Providence Genomics SharePoint portal (internal site) to search the expanding list of FAQs and other content that can help you on this journey.
SharePoint Site ➝
The Providence Molecular Tumor Board offers an exciting and innovative way to find the curated knowledge you seek for your patients about precision medicine.
As a virtual tumor board, we shift the focus to a system-wide perspective. This provides an opportunity for intelligent and thought-provoking interactions with physicians from your own or different disciplines in locations from Alaska to Texas and everywhere in between. Learn how cases just like yours are being or have been handled. Which protocols are most effective? What treatments worked best and in what order?
A patented technology framework runs the tumor board. With our ground-breaking digital pathology tools, you can view information in a multitude of ways. A user interface integrates all the data you need into an accessible, user-friendly, and quickly digestible presentation of the critical data you need—from imaging (radiology and pathology) to EHR data, public studies, national guidelines, and more.
